These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 728911)

  • 1. Overview of the activity of a Brucella abortus preparation, Bru-Pel.
    Youngner JS; Feingold DS; Keleti G
    Cancer Treat Rep; 1978 Nov; 62(11):1915-8. PubMed ID: 728911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activity of an ether-extracted nonviable preparation of Brucella abortus.
    Youngner JS; Keleti G; Feingold DS
    Infect Immun; 1974 Dec; 10(6):1202-6. PubMed ID: 4373393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage activation and antitumor activity of a Brucella abortus ether extract, Bru-Pel.
    Schultz RM; Chirigos MA; Pavlidis NA; Youngner JS
    Cancer Treat Rep; 1978 Nov; 62(11):1937-41. PubMed ID: 103619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of reticuloendothelial system macrophages and enhancement of host resistance to a transplantable osteogenic sarcoma in mice by an extract of Brucella abortus.
    Glasgow LA; Crane JL; Schleupner CJ; Kern ER; Youngner JS; Feingold DS
    Cancer Treat Rep; 1978 Nov; 62(11):1931-5. PubMed ID: 282007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymhocyte stimulatory effect of an ether-extracted preparation of Brucella abortus.
    Stylos WA; Chirigos MA; Lengel CR
    Cancer Treat Rep; 1978 Nov; 62(11):1949-54. PubMed ID: 310345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of a Brucella abortus preparation.
    Keleti G; Feingold DS; Youngner JS
    Infect Immun; 1977 Mar; 15(3):846-9. PubMed ID: 404249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral activity of Brucella abortus preparations; separation of active components.
    Feingold DS; Keleti G; Youngner JS
    Infect Immun; 1976 Mar; 13(3):763-7. PubMed ID: 818014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with recombinant Semliki Forest virus particles expressing translation initiation factor 3 of Brucella abortus induces protective immunity in BALB/c mice.
    Cabrera A; Sáez D; Céspedes S; Andrews E; Oñate A
    Immunobiology; 2009; 214(6):467-74. PubMed ID: 19150742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of resistance to murine osteogenic sarcoma in vivo by an extract of Brucella abortus (Bru-Pel): association with activation of reticuloendothelial system macrophages.
    Glasgow LA; Crane JL; Schleupner CJ; Kern ER; Youngner JS; Feingold DS
    Infect Immun; 1979 Jan; 23(1):19-26. PubMed ID: 106004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage involvement in the antitumor activity of Brucella abortus ether extract against experimental lung carcinoma metastases.
    Schultz RM; Pavlidis NA; Chirigos MA
    Cancer Res; 1978 Oct; 38(10):3427-31. PubMed ID: 99230
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of Corynebacterium parvum, Brucella abortus extract, Bacillus Calmette-Guérin, glucan, levamisole, and tilorone with or without cyclophosphamide on tumor growth, macrophage production, and macrophage cytotoxicity in a murine mammary tumor model.
    Fisher B; Gebhardt M
    Cancer Treat Rep; 1978 Nov; 62(11):1919-30. PubMed ID: 728912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of natural killer cell activity in mice by Bru-Pel.
    Yabu K; Youngner JS; Feingold DS; Keleti G; Gorelik E
    J Immunother (1991); 1991 Oct; 10(5):307-12. PubMed ID: 1790138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection.
    Mallick AI; Singha H; Chaudhuri P; Nadeem A; Khan SA; Dar KA; Owais M
    Vaccine; 2007 May; 25(18):3692-704. PubMed ID: 17296251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of Brucella abortus on growth of ovarian granulosa cell carcinoma].
    Litvinkova NP; Trubcheninova LP; Baryshnikov AIu
    Biull Eksp Biol Med; 1980 Nov; 90(11):600-2. PubMed ID: 6778536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Brucella abortus DNA and RNA vaccines expressing Cu-Zn superoxide dismutase (SOD) gene in cattle.
    Sáez D; Guzmán I; Andrews E; Cabrera A; Oñate A
    Vet Microbiol; 2008 Jun; 129(3-4):396-403. PubMed ID: 18164561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant Brucella abortus proteins that induce proliferation and gamma-interferon secretion by CD4+ T cells from Brucella-vaccinated mice and delayed-type hypersensitivity in sensitized guinea pigs.
    Oliveira SC; Harms JS; Banai M; Splitter GA
    Cell Immunol; 1996 Sep; 172(2):262-8. PubMed ID: 8964089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of an anti-interferon serum on experimental viral pathogenicity in vivo].
    Fauconnier B
    Pathol Biol (Paris); 1971; 19(11):575-8. PubMed ID: 4933621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.